2021

Panel discussion: Improving the pathway of lung cancer patients, can we do it better? A. Šajnic (Zagreb, Croatia), T. Blum (Berlin, Germany), Prof. Marko Jakopovic (Zagreb, Croatia), A. Breški (Zagreb, Croatia), I. Belina (Zagreb, Croatia), G. Hardavella (Athens, Greece), M. J. Catarata (Porto, Portugal) Thursday, 16 December 2021
Translational perspectives in paediatric OSA: Guts and particles lead the way! D. Gozal (Columbia, USA), R. Ersu (Ottawa, Canada) Tuesday, 30November 2021
Panel discussion: COVID-19 – Looking into the Future A. Simonds (London, United Kingdom), G. C. Khilnani (New Delhi, India), J. Chalmers (Dundee, United Kingdom), D. J. Christopher (Vellore, India), S. Joshi (India) Tuesday, 30 November 2021
Debate – Controversies in interstitial lung disease M. Kreuter (Heidelberg, Germany), K. Antoniou (Heraklion, Greece), C. Ravaglia (Forli, Italy), A. Tzouvelekis (Athens, Greece), D. Culver (Cleveland, United States of America), A. Vorselaars (Nieuwegein, Netherlands) Tuesday, 09 November 2021 Access for REGISTERED non-members
COVID-19 vaccination and more A. Yorgancioglu (Konak, Turkey), J. Chorostowska (Warsaw, Poland), T. Welte (Hannover, Germany), M. Akova (Ankara, Turkey), A. Sayiner (Izmir, Turkey) Thursday, 05 November 2021
Occupational dust induced lung diseases R. Cohen (River Forest, USA), E. Fireman (Tel-Aviv, Israel) Tuesday, 19 October 2021
Immunotherapy in severe asthma A. Bossios (Stockholm, Sweden), W. Canonica (Milan, Italy), C. Porsbjerg (Copenhagen, Denmark) Tuesday, 05 October 2021
Occupational COVID-19 R. E. de la Hoz (New York, USA), K. Fennelly (Bethesda, USA) Thursday, 30 September 2021
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight M. Guckenberger (Zürich, Switzerland), T. De Baere (Paris, France), E. Pompeo (, Italy) N. N. Valentin (Salamanca, Spain), Tuesday, 21 September 2021
TB and COVID-19 – a dangerous new combination? Giovanni Battista Migliori (Varese (VA), Italy), Alberto García-Basteiro (Maputo, Mozambique) Thursday, 22 July 2021
Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases T. Blum (Berlin, Germany), J. Cadranel (Paris, France), D. Jovanovic (Belgrade, Serbia) Wednesday, 14 July 2021
Air pollution and the lung in children: the evidence for exposure and prevention measures R. Naidoo (PATS), I. de Kleer (ERS), R. Nantanda (Uganda), J. Usemann (Switzerland) Tuesday, 13 July 2021
Sleep; throughout the pandemic and beyond M. Bonsignore (Palermo, Italy), J. Steier (London, United Kingdom), S. Schiza (Heraklion, Greece), W. Randerath (Solingen, Germany) Monday, 12 July 2021
ERS statement on Philips devices: clinicians’ and patients’ perspectives, and questions to be answered A. Simonds (London, England), W. Randerath (Solingen, Germany), R. Ersu (Ottawa, Canada), J. C. Winck (Vila Nova de Gaia, Portugal), M. Duiverman (Groningen, Netherlands), S. Schiza (Heraklion, Greece), L. Roberti (ELF, Rome, Italy) Thursday, 01 July 2021
ERS guidelines on treatment of sarcoidosis D. Valeyre (Paris, France), Robert P. Baughman (Cincinnati, USA), P. Korsten (Göttingen, Germany) Wednesday, 23 June 2021
Excerpts from the upcoming ERS Monograph on COVID-19 L. Lui (Toronto, Canada), A. Simonds (London, United Kingdom), F. Amati (Milan, Italy), A. Fabre (Dublin, Ireland), S. Ramjug (Manchester, United Kingdom) Tuesday, 15 June 2021
Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD E. Bargagli, (Siena, Italy), E. Renzoni (London, United Kingdom), O. Distler (Zurich, Switzerland), K. Antoniou (Heraklion, Greece), B. Crestani (Paris, France) Monday, 14 June 2021
Neuroendocrine tumours of the lung other than SCLC A.M. Dingemans(Rotterdam, Netherlands), J. Derks (Maastricht, Netherlands) Tuesday, 8 June 2021
Evidence-based eHealth for COPD N. Chavannes (Leiden, Netherlands), M. Vitacca (Brescia, Italy), V. Poberezhets (Vinnytsia, Ukraine) Thursday, 27 May 2021
Physical activity as an outcome measure or as a way to provide feedback to patients. How should it be assessed, analysed and interpreted? H. Demeyer (Leuven, Belgium), A. Nyberg (Umeå, Sweden) Tuesday, 25 May 2021
Challenges in the management of SCLC T. Blum (Berlin, Germany), J. Cadranel (Paris, France), D. Jovanovic (Belgrade, Serbia) Tuesday, 18 May 2021
ERS practice guidelines for the diagnosis of asthma in children aged 5 to 16 years A. Moeller (Zurich, Switzerland), E. Gaillard (Leicester, United Kingdom) Thursday, 22 April 2021
PATS and ERS paediatric webinar: reducing the burden of CAP A. Irungu (PATS, Nairobi, Kenya), Stefan Unger (Edinburgh, United Kingdom), A. Goga (Pretoria, South Africa), Massimiliano Don (Udine, Italy) Thursday, 15 April 2021
Lung diseases and self-management – what is missing? M. Clari (Torino, Italy), J. De Brandt (Diepenbeek, Belgium), C. Kelly (Lancashire, UK), K. Heslop-Marshall (Newcastle upon Tyne, UK), S. Jones (Cambridge, United Kingdom) Tuesday, 13 April 2021
Congenital airway diseases Eber (Graz, Austria), M. Schnater (Rotterdam, Netherlands), L. S. J. Kamphuis (Rotterdam, Netherlands), M. W.H. Pijnenburg (Rotterdam, Netherlands), C. Gotera (Madrid, Spain) Tuesday, 23 March 2021
ERS statement on chronic thromboembolic pulmonary hypertension M. Delcroix (Leuven, Belgium), G. Simonneau (Le Kremlin-Bicêtre, France), E. Mayer (Bad Nauheim, Germany) Thursday, 18 March 2021
ERS short guidelines on COVID-19 management N. Roche (Paris, France), J. Chalmers (Dundee, United Kingdom) Thursday, 4 March 2021
Wearable technologies in respiratory functional assessment I. Vogiatzis (Newcastle upon Tyne, United Kingdom), A. Aliverti (Milan, Italy) Thursday, 25 February 2021
Lung functional imaging S. Bayat (Grenobe, France), G. Parraga (London (ON), Canada), J. M. Wild (Sheffield (South Yorkshire), United Kingdom) Thursday, 11 February 2021
ERS clinical practice guidelines on bronchiectasis in children A. Chang (Australia), A. Kantar (Italy) Tuesday, 2 February 2021
Understanding new vaccines for SARS-CoV-2 and their regulation A. Simonds (London, United Kingdom), T. Welte (Hannover, Germany), M. Cavaleri (Amsterdam, Netherlands), R. Boyton (London, United Kingdom) Monday, 1 February 2021
ERS guideline on withdrawal of inhaled corticosteroids in COPD J. Chalmers (Dundee, United Kingdom), M. Miravitlles (Barcelona, Spain) Thursday, 21 January 2021
IGRAs and other TB infection tests D. Goletti (Rome, Italy), R. Duarte (Porto, Portugal) Tuesday, 12 January 2021